Literature DB >> 4085353

The effects of activated charcoal on digoxin and digitoxin clearance.

G D Park, M J Goldberg, R Spector, G F Johnson, R D Feldman, C K Quee, P Roberts.   

Abstract

The effect of multiple oral doses of activated charcoal on digitalis glycoside kinetics was studied to determine whether an activated charcoal regimen might have utility in treating patients with digitalis toxicity. Normal subjects were given intravenous infusions of digoxin 0.75 mg/70 kg or digitoxin 1 mg/70 kg iv followed by either water alone or water with activated charcoal in divided doses in a randomized crossover design. A subject with chronic renal failure was also given digoxin 0.5 mg/70 kg iv followed by water alone or water with activated charcoal. In six normal subjects, treatment with activated charcoal did not increase digoxin clearance (Cl) significantly (16.79 +/- 1.70 vs. 22.68 +/- 3.51 L/h). However, digitoxin Cl did increase significantly, from 0.24 +/- 0.01 to 0.47 +/- 0.04 L/h. In the renal failure subject, digoxin Cl increased from 3.6 L/h to 10.1 L/h. We conclude that the activated charcoal regimen is probably useful in patients with digitoxin toxicity. Although similar benefit is limited in patients with normal renal function who develop digoxin toxicity, it is possible that activated charcoal will be useful in patients with prolonged digoxin elimination due to renal dysfunction.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4085353     DOI: 10.1177/106002808501901216

Source DB:  PubMed          Journal:  Drug Intell Clin Pharm        ISSN: 0012-6578


  7 in total

Review 1.  Activated charcoal in the treatment of drug overdose. An update.

Authors:  W Palatnick; M Tenenbein
Journal:  Drug Saf       Date:  1992 Jan-Feb       Impact factor: 5.606

Review 2.  Pharmacological treatment of cardiac glycoside poisoning.

Authors:  Darren M Roberts; Gamini Gallapatthy; Asunga Dunuwille; Betty S Chan
Journal:  Br J Clin Pharmacol       Date:  2015-12-15       Impact factor: 4.335

3.  Effect of oral activated charcoal on tobramycin clearance.

Authors:  R L Davis; J R Koup; R A Roon; K E Opheim; A N Smith
Journal:  Antimicrob Agents Chemother       Date:  1988-02       Impact factor: 5.191

4.  Pharmacokinetics of digoxin cross-reacting substances in patients with acute yellow Oleander (Thevetia peruviana) poisoning, including the effect of activated charcoal.

Authors:  Darren M Roberts; Emma Southcott; Julia M Potter; Michael S Roberts; Michael Eddleston; Nick A Buckley
Journal:  Ther Drug Monit       Date:  2006-12       Impact factor: 3.681

Review 5.  Pharmacokinetic considerations in clinical toxicology: clinical applications.

Authors:  Darren M Roberts; Nick A Buckley
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

6.  Effect of orally administered activated charcoal on vancomycin clearance.

Authors:  R L Davis; R A Roon; J R Koup; A L Smith
Journal:  Antimicrob Agents Chemother       Date:  1987-05       Impact factor: 5.191

Review 7.  Applied clinical pharmacology and public health in rural Asia--preventing deaths from organophosphorus pesticide and yellow oleander poisoning.

Authors:  Michael Eddleston
Journal:  Br J Clin Pharmacol       Date:  2013-05       Impact factor: 4.335

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.